Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China flag China · Delayed Price · Currency is CNY
11.84
-0.04 (-0.34%)
Apr 30, 2025, 3:00 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2017
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '17
Respiratory System Medications
1.30B
Log In
Log In
Log In
Log In
Blood Medications
112.37M
Log In
Log In
Log In
Log In
Gynecological Medications
77.38M
Log In
Log In
Log In
Log In
Gynecological Medications Growth
79.81%
Log In
Log In
Log In
Log In
Tonic Medicine
46.33M
Log In
Log In
Log In
Log In
Cardiovascular and Cerebrovascular Drugs
41.33M
Log In
Log In
Log In
Log In
Orthopedic Medication
35.44M
Log In
Log In
Log In
Log In
Other Business
512.18K
Log In
Log In
Log In
Log In
Other Business Growth
53.42%
Log In
Log In
Log In
Log In
Other
21.55M
Log In
Log In
Log In
Log In
Other Growth
-59.40%
Log In
Log In
Log In
Log In
Open Throat Sword Spray (including Children's Type)
-
Log In
Log In
Log In
Log In
Open Throat Sword Spray (including Children's Type) Growth
-
Log In
Log In
Log In
Log In
Strong Gastrodia Eucommia Capsules
-
Log In
Log In
Log In
Log In
Strong Gastrodia Eucommia Capsules Growth
-
Log In
Log In
Log In
Log In
Open Throat Spray Agent
-
Log In
Log In
Log In
Log In
Open Throat Spray Agent Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2017
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '17
China
1.63B
Log In
Log In
Log In
Log In
China Growth
36.10%
Log In
Log In
Log In
Log In